EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

SARS-CoV-2 Omicron subvariant genomic variation associations with immune evasion in Northern California: A retrospective cohort study

Joshua R Nugent iD, Mariah S Wood, Liyan Liu, Teal Bullick iD, Jeffrey M Schapiro, Phacharee Arunleung iD, Gautham Gautham iD, Shiffen Getabecha, Christina Morales, Laura B Amsden iD, Crystal A Hsiao iD, Debra A Wadford iD und 2 weitere

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0319218 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift PLOS ONE, 2025. Verfasst von Joshua R Nugent und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Research, Kaiser Permanente Northern California, Oakland, California, United States of America. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Immune Evasion, Genome, Viral. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NCEZID CDC HHS, Rockefeller Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The possibility of association between SARS-CoV-2 genomic variation and immune evasion is not known among persons with Omicron variant SARS-CoV-2 infection.

Methods

In a retrospective cohort, using Poisson regression adjusting for sociodemographic variables and month of infection, we examined associations between individual non-lineage defining mutations and SARS-CoV-2 immunity status, defined as a) no prior recorded infection, b) not vaccinated but with at least one prior recorded infection, c) complete primary series vaccination, and/or d) primary series vaccination and ≥1 booster. We identified all non-synonymous single nucleotide polymorphisms (SNPs), insertions and deletions in SARS-CoV-2 genomes with ≥5% allelic frequency and population frequency of ≥5% and ≤95%. We also examined correlations between the presence of SNPs with each other, with subvariants, and over time.

Results

Seventy-nine mutations met inclusion criteria. Among 15,566 persons infected with Omicron SARS-CoV-2, 1,825 (12%) were unvaccinated with no prior recorded infection, 360 (2%) were unvaccinated with a recorded prior infection, 13,381 (86%) had a complete primary series vaccination, and 9,172 (58%) had at least one booster. After examining correlation between SNPs, 79 individual non-lineage defining mutations were organized into 38 groups. After correction for multiple testing, no individual SNPs or SNP groups were significantly associated with immunity status levels.

Conclusions

Genomic variation identified within SARS-CoV-2 Omicron specimens was not significantly associated with immunity status, suggesting that contribution of non-lineage defining SNPs to immune evasion is minimal. Larger-scale surveillance of SARS-CoV-2 genomes linked with clinical data can help provide information to inform future vaccine development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19Immune EvasionGenome, ViralHumansPolymorphism, Single NucleotideRetrospective StudiesMaleFemaleCaliforniaMiddle AgedAdultMutationAged

Autor:innen und Institutionen

  • Division of Research, Kaiser Permanente Northern California, Oakland, California, United States of America.
  • Viral and Rickettsial Disease Laboratory, Center for Laboratory Sciences, California Department of Public Health, Richmond, California, United States of America.
  • The Permanente Medical Group, Kaiser Permanente Northern California, Oakland, California, United States of America.
  • Innovative Genomics Institute, University of California, Berkeley, California, United States of America.
  • Department of Infectious Diseases, Oakland Medical Center, Kaiser Permanente Northern California, Oakland, California, United States of America.
  • Physician Researcher Program, Kaiser Permanente Northern California, Oakland, California, United States of America.

ORCID-Profile: Joshua R Nugent, Teal Bullick, Phacharee Arunleung, Gautham Gautham, Laura B Amsden, Crystal A Hsiao, Debra A Wadford, Stacia K Wyman, Jacek Skarbinski

Förderung

  • NCI NIH HHS
  • NCEZID CDC HHS
  • Rockefeller Foundation
  • National Cancer Institute
  • Permanente Medical Group Delivery Science and Applied Research Program
  • Packard Foundation
  • Sergey Brin Family Foundation
  • Centers for Disease Control and Prevention, Epidemiology and Laboratory Capacity for Infectious Diseases

Zitieren

APA

Nugent, J. R., Wood, M. S., Liu, L., Bullick, T., Schapiro, J. M., Arunleung, P., Gautham, G., Getabecha, S., Morales, C., Amsden, L. B., Hsiao, C. A., Wadford, D. A., Wyman, S. K., & Skarbinski, J. (2025). SARS-CoV-2 Omicron subvariant genomic variation associations with immune evasion in Northern California: A retrospective cohort study. PLOS ONE. https://doi.org/10.1371/journal.pone.0319218

Vancouver

Nugent JR, Wood MS, Liu L, Bullick T, Schapiro JM, Arunleung P, et al. SARS-CoV-2 Omicron subvariant genomic variation associations with immune evasion in Northern California: A retrospective cohort study. PLOS ONE. 2025. doi:10.1371/journal.pone.0319218

BibTeX
@article{Nugent2025,
  author = {Nugent, Joshua R and Wood, Mariah S and Liu, Liyan and Bullick, Teal and Schapiro, Jeffrey M and Arunleung, Phacharee and Gautham, Gautham and Getabecha, Shiffen and Morales, Christina and Amsden, Laura B and Hsiao, Crystal A and Wadford, Debra A and Wyman, Stacia K and Skarbinski, Jacek},
  title = {SARS-CoV-2 Omicron subvariant genomic variation associations with immune evasion in Northern California: A retrospective cohort study},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0319218}
}
Kostenlos starten →